Literature DB >> 10423115

Is cancer related to hypertension or to its treatment?

A F Lever1, D J Hole, C R Gillis, G T McInnes, P A Meredith, L S Murray, J L Reid.   

Abstract

Three questions related to cancer and blood pressure are discussed. (i) Is cancer related in some way to hypertension, or to blood pressure? Several studies show a relation of blood pressure and cancer in populations. However, our own experience, based on a cohort of 15,411 subjects with BP measured in the 1970s and with 1,392 fatal cancers since, shows no relation of cancer risk and diastolic pressure. Nor were cancer numbers (n=72) observed in the 1,078 untreated hypertensives of the Glasgow Blood Pressure Clinic different from those expected (n=71.2) in a control population matched for age, sex and smoking habit. (ii) Do antihypertensive drugs promote cancer? Atenolol and calcium channel blockers have been suspected of this, but evidence of larger studies, including two of our own, is negative: relative risk for cancer in our patients taking CCB was 1.02 (CI 0.82-1.27). (iii) Do antihypertensive drugs protect against cancer? A study of ours based on the Glasgow Clinic raises this possibility: relative risk for incident cancer amongst 1,559 patients taking ACE inhibitor was 0.72 (CI 0.55-0.92).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10423115     DOI: 10.3109/10641969909061022

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  2 in total

1.  Preparation of bioactive peptides with high angiotensin converting enzyme inhibitory activity from winged bean [Psophocarpus tetragonolobus (L.) DC.] seed.

Authors:  Wan Abd Al-Qadr Imad Wan Mohtar; Azizah Abdul Hamid; Suraini Abd-Aziz; Sharifah Kharidah Syed Muhamad; Nazamid Saari
Journal:  J Food Sci Technol       Date:  2013-01-08       Impact factor: 2.701

2.  Evidence for aldosterone-dependent growth of renal cell carcinoma.

Authors:  Sharon King; Susan Bray; Sarah Galbraith; Lesley Christie; Stewart Fleming
Journal:  Int J Exp Pathol       Date:  2014-05-07       Impact factor: 1.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.